A partial structure for the γ-aminobutyric acid (GABAA) receptor is derived from the model for the nicotinic acetylcholine receptor The anion-exchange protein of cell membranes is related to the GABAA receptor  by Kosower, Edward M.
Volume 231, number 1, 5-10 FEB 05688 April 1988 
Hypothesis 
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The anion-exchange protein of cell membranes is related to the GABAA 
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Based on the nicotinic acetylcholine receptor model [(1987) Eur. J. B&hem. 168,43 l-4491, a partial model is constructed 
for the exobilayer portion of the GABA, receptor, an approach justified by the superfamily relationship of the two recep- 
tors [(1987) Nature 328, 221-2271. The model predicts succesfully the excess positive charge on interior strands which 
constitute the ligand-responsive portion of the receptor. Binding to GABA expands the exobilayer portion of the receptor, 
opening a pathway to a chloride channel. Separate binding sites for antianxiolytics (benzodiazepines) and hypnotics (bar- 
biturates) are suggested, with prolongation of chloride entry projected as a consequence of stabilization of the open form. 
The anion-exchange protein (AEP) of membranes (band 3 of red blood cell membranes) is similar in some respects to 
the y-aminobutyric acid (GABA*) receptor. Both proteins are inhibited and labeled by diisocyanatostilbenedisulfonate 
(DIDS), both transport Cl- and HCO;, and both are membrane proteins. Starting with the lysines known to be labeled 
in band 3 protein, searches of the amino acid sequences of the GABAA receptor OT- and &subunits reveal at least 4 reason- 
ably homologous sequences. The relationship between AEP and GABAA receptor leads to the idea that the chloride/ 
bicarbonate channel may be the ancestor of all ligand-gated channels, with ligand gating by y-aminobutyric acid and 
acetylcholine arising later in evolution. 
GABA receptor; Nicotinic acetylcholine receptor; Anion-exchange protein; Amino acid sequence; Sequence homology; Structural model 
1. INTRODUCTION 
Superfamily relationships have been discovered 
among ligand (photon) activated G-protein recep- 
tors [l-6], voltage-gated ion channels [7- 131 and 
ligand-activated ion channel receptors [14-161 on 
the basis of amino acid sequence homologies and 
domain distributions. These have stimulated the 
hope that conclusions on the structure of one 
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member of a superfamily might be used to 
elucidate the structure of another member of the 
same superfamily [ 17,181. It is accepted that, 
within families like those of the opsins [19] and 
nicotinic acetylcholine receptors [20], homologous 
structures occur. 
The amino acid sequences for both subunits of 
the y-aminobutyric acid (GABAA) receptor and 
one subunit of the glycine receptor have been 
carefully examined. The structural features iden- 
tified are. four hydrophobic transmembrane cy- 
helices and an exobilayer ‘disulfide loop’ [21]. It 
seemed worthwhile to test the arrangements deduc- 
ed in the model for the nicotinic acetylcholine 
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(nACh) receptor on the GABA. receptor so that a 
plausible structural and dynamic model might be 
available for further analysis. 
A recent report suggested that bicarbonate can 
exit through the GABAA channel which normally 
admits chloride into the cell [22,23]. It seemed 
desirable to make a comparison between the amino 
acid sequences of the GABA* and glycine recep- 
tors and those of the cell membrane anion- 
exchange proteins (AEPs) which exchange HCO; 
for Cl-. The prototypical AEP is the red blood cell 
AEP (band 3 in red blood cell membrane protein 
electrophoretograms) [24-261. The red blood cell 
AEP was included among the group of chloride 
channels similar to the GABAA and glycine recep- 
tors [27]. 
We now report that a partial model for the 
GABAA receptor can be derived from the nACh 
receptor model on the basis of the superfamily 
relationship. In addition, a number of homologous 
amino acid sequences in the GABAA and glycine 
receptors and the AEP suggest a possible common 
origin. Given the likelihood that chloride was pre- 
sent in the primitive environment before GABAA, 
it seems plausible that the GABAA receptor may 
have evolved from the chloride AEP, The relation- 
ship of the GABAA receptor to the nACh receptor 
then implies that ligand-gated channels for cations 
are derived from the same origin. The existence of 
an acetylcholine-activated receptor in Aplysia 
which controls the entry of Cl- is consistent with 
this proposition [28]. The calcium channel has 
been suggested as precursor for the sodium chan- 
nel [29]. 
2. RESULTS AND DISCUSSION 
The superfamily relationship between the 
GABA* and nACh receptors implies that a struc- 
tural similarity might exist. Cartoons for receptors 
are attractive but do not have sufficient physical 
and chemical detail to explain receptor behavior on 
the molecular level. We therefore modeled the 
GABA,, receptor using the scheme developed for 
the nACh receptor [30]. The exobilayer portion of 
the GABAA receptor is divided into 20 amino acid 
sections to obtain 11 strands analogous to those 
proposed for the nACh receptor model. An overall 
view of the strand arrangement is shown in fig. 1. 
The lower strands (5,6,9-11) are on the inner side 
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Fig. 1. Schematic exobilayer strand arrangements for the LY- and 
&subunits of the y-aminobutyric acid @ABA*) receptor. 
Charges for each strand of the a-subunit are shown next to each 
strand. The net charges for the &subunit are indicated in 
parentheses. The charges on the strands are asymmetrically 
distributed in two ways. First, the net charge of the outer 
strands is negative while that of the inner strands is positive. 
Second, the charges on the inner strands, those which face the 
pathway to the channel, are quite asymmetric, the right-hand 
and center strands being very positive, while the strands on the 
left are negative. The strand arrangements are those shown in 
[30] for the nACh receptor. 
of the exobilayer portion of the receptor. Charged 
amino acids (Lys+, Arg+, Glu-, Asp-) are counted 
and the net charges shown next to each strand. No 
corrections are made for the possibility that adja- 
cent amino acids might point in opposite directions 
on a &strand. The surprising result is that the net 
charge is asymmetrically distributed, with the inner 
strands positive and the outer strands negative. 
The positively charged regions of the inner strands 
should favor the association and passage of Cl- to 
the bilayer channel. Barnard et al. [14,21] pointed 
out that there were many positive charges near the 
bilayer, but could not define their relationships. 
The ‘flower’ model for the nACh receptor is a 
reasonable choice for the GABAA receptor, as 
shown in fig.2, since the phenomena of activation 
and desensitization are parallel in the two cases 
[3 11. The composition of the receptor, C&Z, is dif- 
ferent from that of the nACh receptor. Activation 
of the receptor opens up a pathway to Cl-, which 
should involve the positively charged regions of the 
strands. Activation is achieved by 2 molecules of 
GABAA binding between two subunits of the 
receptor, either two cy- or two @subunits. Desen- 
sitization involves rotation of the GABAA 
molecule(s) to a position parallel to the strands, 
allowing the flower to close somewhat and cutting 
off the flow of Cl-. 
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Fig.2. Activation and desensitization mechanism for the GABAA receptor. Two GABA molecules bind to the interior of the exobilayer 
portion of the receptor, opening a pathway for Cl-. A reorientation of the GABA molecule or molecuIes leads to a partial closing 
of the pathway and blocks the flow of Cl-. (Adapted from [30].) 
Antianxiolytic and hypnotic drugs inhibit ner- 
vous activity by increasing the open time for the 
GABAA chloride channel. A schematic mechanism 
for the conversion of the resting (closed channel) 
to the activated state (open channel) is shown in 
fig.3. Single group rotation [30] changes the orien- 
tation of the binding groups, and combination of 
GABA with the receptor (an WY site is arbitrarily 
chosen) expands the receptor from approx. 16 A to 
21 A for the cy-(Y dimension. The expansion opens 
up a pathway to the bilayer channel, which for the 
moment is unspecified (see below and [14,21]). 
Prolonging the channel open time might be achiev- 
ed through binding of drugs to the cu5/,&3 and 
,&4/cr9 strand combinations. The drug complex 
stabilizes the activated, expanded state of the 
receptor, retarding the closure of the chloride 
pathway. The benzodiazepine-binding site must be 
accessible to the milieu since a benzodiazepine af- 
finity column is used to purify the receptor. The 
model accounts for two different types of pro- 
longations for channel opening, one due to an- 
tianxiolytics and the other due to depressants. 
Since the chloride pathway is close to the (u5/,&3 
corner, we suppose this to be the depressant- 
binding site. Channel blocking inhibitors like 
picrotoxin and t-butylbicyclophosphorothionate 
[32,33] bind on the interior to several positively 
charged groups. ‘A detailed hydrogen-bonding 
scheme for the binding of barbiturate to two pep- 
tide strands shows quite clearly that the strands 
must be antiparallel (fig.3). More specific binding 
site groups for GABAA might have been chosen us- 
ing the same theoretical approach as that used for 
ACh [30], but has not yet been tried. Experimental 
and genetic data for checking prospective binding 
sites will surely appear within a year or two. 
2.1. Relationship between GABAA receptor and 
AEP 
The AEP of membranes (band 3 of red blood 
cell membranes) is similar in some respects to the 
GABAA receptor. Both proteins are inhibited 
and labeled by diisocyanatostilbenedisulfonate 
(DIDS), both transport Cl- and HC03, and both 
are membrane proteins. 
The finding that HCOp could exit from cells 
through the chloride channel of the GABAA recep- 
tor suggested that a search be made for a possible 
connection between the receptor and AEP. Amino 
acid sequences were chosen for examination on the 
basis of their importance to the activity of AEP. 
Starting with the lysines known to be labeled in 
band 3 protein, searches of the amino acid se- 
quences of the GABA* receptor LY- and ,&subunits 
were begun with critical pairs. Pairs comprising the 
labeled lysines plus a neighboring amino acid were 
selected, all contained within the amino acid se- 
quences compared by Demuth et al. (fig.5 in [24]) 
for the ‘membrane domains’ of HKB3 (human 
non-erythroid band 3 protein) [24], MEB3 (mouse 
erythrocyte band 3 [25]) and HEB3 human 
erythrocyte band 3, 72 peptide amino acid se- 
quence [26]. The tyrosine included in the search is 
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labeled extracellularly by radioiodination. Se- 
quences which contained the pairs were then ex- 
amined for matches in neighboring segments. The 
search revealed at least 4 reasonably homologous 
sequences. 
The matches found at critical segments of the 
GABAA receptor are not present in randomly 
selected portions of the receptor amino acid se- 
quences. We can conclude that there is a relation- 
ship between the AEP and the GABAA receptor. 
The results are shown in the homology search 
scheme. 
Given the high probability that chloride was pre- 
sent in the primitive environment, it seems 
reasonable to propose that a chloride channel (or 
APP) preceded ligand-gated chloride channels in 
evolution. Hille [29] suggested that calcium chan- 
nels were the earliest of the voltage-gated channels. 
Apparently, chloride and calcium channels are the 
elementary primitive channels. A link between 
these two ‘primary’ classes is that both are in- 
hibited by pyrethroids [34]. 
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Fig.3. Schematic illustration of the mechanism of activation of the GABAA receptor by GABA, in which the resting (closed) form 
of the receptor is converted into the expanded (opened) form of the receptor. Lines represent he strands shown individually in fig.1. 
The closed form is estimated to have a separation of 16 A between opposed subunits, whereas the opened form has an (Y-U separation 
of approx. 21 A. The binding site groups for GABA are shown in a particular initial conformation in the resting form, but change 
orientation by single group rotation in the activated form. The binding sites for antianxiolytics and hypnotics between two antiparallel 
peptide strands,are illustrated with detailed hydrogen-bonding schemes for a barbiturate and a benzodiazepine. The drug-binding sites 
must include hydrophobic groups shown as the side chain of leucine for barbiturate and as R for the benzodiazepine. 
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2.2. Chloride channel in bilayer the binding of Cl- [35] may be used to infer the 
As pointed out by Barnard and co-workers 1141, presence of an arginine in the channel region of the 
amphiphilic segments like those noted for the red blood cell AEP. The mechanism proposed by 
nACh receptor [30] cannot be located in either the Falke and Chan 1361 for translocation of ions in 
GABA* or glycine receptors. The finding that AEP seems quite different from that envisaged 
1,2-cyclohexanedione, an arginine-binding agent, here for the GABAA receptor. Nevertheless, it is 
is an AEP channel blocker without interfering with similar in the sense that a physical barrier opens or 
Scheme 1 
Homology search 
Sequences containing pairs derived from MEB3 proteins: 
MEB 448 EKTRNLMGUSELLISTA LYS 449 I253 
MEB 556 FSKLIKIFQDYPLQQTY LYS 558, 561 I253 
MEB 606 LRKFKNSTYFPGKLRRU Lys 608, 610, 618 124, 263 
MEB 645 TYTQKLSUPDGLKUSNS Tyr 646 C24, 371 
FPS = functionally plausible substitutions 
Matches: 
117 
KLLRITEDGTL 
KLIKIFQDYPL 
KLUKIFQEHPL 
557 
380 
RKPMSSREGY GR 
RKFKNSTYFPGK 
RKFKNSRFFPGR 
RKFKNSSYFPGK 
607 
196 
KKUEFTTGAYPRL 
RKFKNSTYFPGKL 
RKFMSRFFPGRI 
RKFKNSSYFPGKL 
607 
WMA-o 
MEB3 
HK83 
Ident ical FPS Simi 1 ar TOTAL 
4/l 1 3/11 l/l 1 Wll 
4/l 1 3/11 l/l 1 8/I 1 
MWA-P 
MEB3 
HKB3 
HE03 
GAB+B 
MEB3 
HKB3 
HE83 
4/12 
6/12 
4112 
3113 4113 - 7/13 
2/13 4113 - 6/13 
2/13 5/13 - 7113 
l/12 
l/l2 
5112 
6112 
5112 
347 
SYTPNmRGD @&A-o 
TYTQKLSUPD MEB3 
TYTQKLSVPS HKB3 
TYTQ.... HE83 
646 
4/10 l/l0 - 5110 
3110 l/l0 - 4/10 
2/4 l/4 - 314 
The MEB numbering system [25] is used to denote the amino acid sequences [24] 
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closes the pathway for Cl-. The question of the 
presence of another transmembrane segment be- 
tween M3 and M4, as well as the related question 
of the orientation of M4 is best left for the future, 
pending further experimental data. As pointed out 
elsewhere [30], there is no really persuasive 
evidence concerning the orientation of M4 in the 
nACh receptor and whether or not it ends extra- or 
intracellularly. 
3. CONCLUSIONS 
The present partial model for the GABA* recep- 
tor provides a reasonable basis for further work on 
the structure of the receptor. Further studies using 
molecular graphics might identify the binding sites 
for GABA and channel-opening drugs. Drug 
design for two important classes of compounds 
might be carried in new directions by the present 
approach. 
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